Sorafenib rechallenge in patients with metastatic renal cell carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib rechallenge in patients with metastatic renal cell carcinoma
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 110, Issue 6b, Pages E228-E234
Publisher
Wiley
Online
2012-02-15
DOI
10.1111/j.1464-410x.2011.10905.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases
- (2011) Camillo Porta et al. BJU INTERNATIONAL
- Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
- (2011) E. Herrmann et al. WORLD JOURNAL OF UROLOGY
- A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options
- (2010) Joaquim Bellmunt et al. BJU INTERNATIONAL
- Sequential therapy in renal cell carcinoma
- (2010) Bernard Escudier et al. CANCER
- Sunitinib rechallenge in metastatic renal cell carcinoma patients
- (2010) Ivan N. Zama et al. CANCER
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Sequential use of targeted agents in the treatment of renal cell carcinoma
- (2010) Thomas E. Hutson et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Experience with sorafenib and adverse event management
- (2010) Joaquim Bellmunt et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET
- (2010) Thomas E. Hutson et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy
- (2010) Michael M. Vickers et al. UROLOGY
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2009) M.P. Sablin et al. JOURNAL OF UROLOGY
- Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
- (2009) Kaja Zimmermann et al. ONCOLOGY
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
- (2008) Christian Eichelberg et al. EUROPEAN UROLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy
- (2007) Ila Tamaskar et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now